Target Name: OR5T2
NCBI ID: G219464
Review Report on OR5T2 Target / Biomarker Content of Review Report on OR5T2 Target / Biomarker
OR5T2
Other Name(s): Olfactory receptor 5T2 | Olfactory receptor OR11-177 | OR5T2_HUMAN | Olfactory receptor family 5 subfamily T member 2 | olfactory receptor family 5 subfamily T member 2 | Olfactory receptor, family 5, subfamily T, member 2 | OR11-177 | olfactory receptor OR11-177

OR5T2: The Unlocking the Secrets of the Human Nose

The human nose, an essential organ for sensing the world around us, has long fascinated researchers and scientists. This complex structure, which is both sensitive and capable of recognizing thousands of scents, has led to a wealth of knowledge about the chemical signals that our sense of smell detects. One of the key molecules responsible for this sense is the olfactory receptor 5T2 (OR5T2), which is a protein that is expressed in the nasal epithelial cells that line the olfactory passages.

OR5T2 is a member of the family of G protein-coupled receptors (GPCRs), which are a large family of transmembrane proteins that play a crucial role in cellular signaling. GPCRs are known for their ability to transmit signals from the cell surface to inside the cell, allowing them to regulate a wide range of physiological processes, including sensory perception, inflammation, and metabolism.

The OR5T2 gene, which encodes the OR5T2 protein, was first identified in the 1990s by researchers at the University of California, San Diego. Since then, studies have demonstrated that OR5T2 is highly expressed in the olfactory epithelial cells, which line the olfactory passages in the nasal cavity. OR5T2 is also known to be involved in the function of the olfactory system, which is responsible for detecting and interpreting the scents that surround us.

OR5T2 has been linked to a wide range of physiological processes that are important to human health. For example, studies have shown that high levels of OR5T2 expression are associated with an increased risk of developing breast cancer, as well as with poor immune function and increased vulnerability to infection. Additionally, OR5T2 has been shown to play a role in the development of neurodegenerative diseases, such as Alzheimer's and Parkinson's disease.

Despite these promising findings, much more research is needed about the role of OR5T2 in human health and disease. One reason for this is that our understanding of the molecular mechanisms that underlie OR5T2 function is still limited. While researchers have identified that OR5T2 is involved in the regulation of ion channels and intracellular signaling pathways, much of the details of its underlying biology remain shrouded in mystery.

One way to gain insight into the OR5T2 signaling pathway is to study its downstream targets. These are the molecules that are activated by the presence of a particular ligand, such as a drug or a chemical messenger. The identification and characterization of OR5T2 downstream targets is an important step in understanding how the OR5T2 signaling pathway works.

One of the most promising areas of research is the study of the potential therapeutic benefits of targeting OR5T2. Given its involvement in a wide range of physiological processes, it is an attractive target for the development of new treatments for a variety of diseases. For example, studies have shown that inhibiting OR5T2 signaling has the potential to treat breast cancer, by suppressing the growth of cancer cells that have been shown to be sensitive to the drug.

Another promising approach to targeting OR5T2 is the use of small molecules, which are drugs that can modulate the activity of OR5T2 without disrupting its function. Researchers have developed a range of small molecules that are currently being tested as potential therapeutic agents for a variety of diseases, including breast cancer, neurodegenerative diseases, and respiratory infections.

While the development of new treatments for diseases associated with OR5T2 signaling is an exciting area of research, it is also important to consider the potential implications of these treatments. As with any new drug, the potential risks and benefits must be carefully evaluated before they are brought

Protein Name: Olfactory Receptor Family 5 Subfamily T Member 2

Functions: Odorant receptor

The "OR5T2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about OR5T2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

OR5T3 | OR5V1 | OR5W2 | OR6A2 | OR6B1 | OR6B2 | OR6B3 | OR6C1 | OR6C2 | OR6C3 | OR6C4 | OR6C65 | OR6C70 | OR6C74 | OR6C75 | OR6C76 | OR6F1 | OR6J1 | OR6K2 | OR6K3 | OR6M1 | OR6N1 | OR6N2 | OR6P1 | OR6Q1 | OR6R2P | OR6S1 | OR6T1 | OR6W1P | OR6X1 | OR6Y1 | OR7A10 | OR7A17 | OR7A5 | OR7C1 | OR7C2 | OR7D1P | OR7D2 | OR7D4 | OR7E104P | OR7E109P | OR7E121P | OR7E122P | OR7E125P | OR7E13P | OR7E140P | OR7E14P | OR7E155P | OR7E156P | OR7E19P | OR7E22P | OR7E24 | OR7E25P | OR7E29P | OR7E37P | OR7E41P | OR7E47P | OR7E5P | OR7E62P | OR7E84P | OR7E85BP | OR7E87P | OR7E91P | OR7E94P | OR7G1 | OR7G2 | OR7G3 | OR7M1P | OR8A1 | OR8B12 | OR8B2 | OR8B3 | OR8B4 | OR8B6P | OR8B7P | OR8B8 | OR8D1 | OR8D2 | OR8D4 | OR8F1P | OR8G1 | OR8G2P | OR8G3P | OR8G5 | OR8G7P | OR8H1 | OR8H2 | OR8H3 | OR8I2 | OR8J1 | OR8J3 | OR8K1 | OR8K3 | OR8K5 | OR8S1 | OR8U1 | OR8U3 | OR8U8 | OR9A1P | OR9A2